Individual treatment effects in randomized trials with binary outcomes

被引:24
作者
Gadbury, GL [1 ]
Iyer, HK
Albert, JM
机构
[1] Univ Missouri, Dept Math & Stat, Rolla, MO 65409 USA
[2] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA
[3] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA
关键词
clinical trials; contingency tables; potential response; subject-treatment interaction;
D O I
10.1016/S0378-3758(03)00115-0
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
A potential outcomes framework is used to define individual treatment effects in a randomized design comparing two treatments, T and C. When the outcome variable is binary, individual effects may take on one of three values, 0, 1, -1, at any given point in time, but these "individual effects" cannot be measured in practice. Often, in clinical trials, an average effect of the treatment is estimated and a superior treatment is determined from this estimate. However, there may W a proportion of the population that responds favorably to T and another proportion that responds more favorably to C if individual treatment effects vary widely in the population. These proportions are nonidentifiable using data from a two sample completely randomized design,,but knowledge regarding their potential magnitude is crucial for assessing the risk involved in administering a treatment to an individual. We produce identifiable bounds for these proportions using data from an unmatched 2 x 2 table and then demonstrate the advantages to matching in a matched-pairs design. The advantages hinge on the quality of the matching criteria. We present an extended matched-pairs design that allows estimation of refined bounds. A constructed data example is used to compare the information about individual treatment heterogeneity, and its consequences, that can be gleaned from the different designs. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 14 条
[1]  
[Anonymous], 1958, Planning of Experiments
[2]   Testing drug response in the presence of genetic information: sampling issues for clinical trials [J].
Cardon, LR ;
Idury, RM ;
Harris, TJR ;
Witte, JS ;
Elston, RC .
PHARMACOGENETICS, 2000, 10 (06) :503-510
[3]   RANDOMIZATION MODELS FOR MATCHED AND UNMATCHED 2 BY 2 TABLES [J].
COPAS, JB .
BIOMETRIKA, 1973, 60 (03) :467-476
[4]  
Elston RC, 1999, STAT MED, V18, P741, DOI 10.1002/(SICI)1097-0258(19990330)18:6<741::AID-SIM64>3.0.CO
[5]  
2-U
[6]  
EZDINLI E, 1976, CANCER, V38, P1050
[7]   Unit-treatment interaction and its practical consequences [J].
Gadbury, GL ;
Iyer, HK .
BIOMETRICS, 2000, 56 (03) :882-885
[8]   Randomization inference and bias of standard errors [J].
Gadbury, GL .
AMERICAN STATISTICIAN, 2001, 55 (04) :310-313
[9]   Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205
[10]  
MARSHALL A, 1997, NAT BIOTECHNOL, V15, P955